Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Prognostic relevance of molecular subtypes and master regulators in pancreatic ductal adenocarcinoma ; volume:16 ; number:1 ; day:12 ; month:8 ; year:2016 ; pages:1-15 ; date:12.2016
BMC cancer ; 16, Heft 1 (12.8.2016), 1-15, 12.2016
- Creator
-
Janky, Rekin’s
- Contributor
-
Binda, Maria Mercedes
Allemeersch, Joke
Van den broeck, Anke
Govaere, Olivier
Swinnen, Johannes V.
Roskams, Tania
Aerts, Stein
Topal, Baki
SpringerLink (Online service)
- DOI
-
10.1186/s12885-016-2540-6
- URN
-
urn:nbn:de:1111-2016091010443
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:53 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Janky, Rekin’s
- Binda, Maria Mercedes
- Allemeersch, Joke
- Van den broeck, Anke
- Govaere, Olivier
- Swinnen, Johannes V.
- Roskams, Tania
- Aerts, Stein
- Topal, Baki
- SpringerLink (Online service)
Other Objects (12)
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Immunophenotypes of pancreatic ductal adenocarcinoma : Meta-analysis of transcriptional subtypes
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma
CYP3A5 as mediator of drug resistance in different subtypes of pancreatic ductal adenocarcinoma
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
CSTF2 mediated mRNA N 6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Characterization and targeting of ribosome biogenesis in cellular and tissue subtypes of pancreatic ductal adenocarcinoma
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Immunophenotypes of pancreatic ductal adenocarcinoma : Meta-analysis of transcriptional subtypes
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma
CYP3A5 as mediator of drug resistance in different subtypes of pancreatic ductal adenocarcinoma
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
CSTF2 mediated mRNA N 6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma
Characterization and targeting of ribosome biogenesis in cellular and tissue subtypes of pancreatic ductal adenocarcinoma
Plasma Metabolome Profiling Identifies Metabolic Subtypes of Pancreatic Ductal Adenocarcinoma
Immunophenotypes of pancreatic ductal adenocarcinoma : Meta-analysis of transcriptional subtypes
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Identification and characterization of molecular subtypes of human pancreatic ductal adenocarcinoma
Gene expression profiling of 1200 pancreatic ductal adenocarcinoma reveals novel subtypes
Prognostic relevance of lactate dehydrogenase in advanced pancreatic ductal adenocarcinoma patients
The clinical relevance of the Hippo pathway in pancreatic ductal adenocarcinoma
CYP3A5 as mediator of drug resistance in different subtypes of pancreatic ductal adenocarcinoma
Cytokeratin 6 identifies basal-like subtypes of pancreatic ductal adenocarcinoma with decreased survival
CSTF2 mediated mRNA N 6-methyladenosine modification drives pancreatic ductal adenocarcinoma m6A subtypes
CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma